Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

38.93USD
17 Apr 2014
Price Change (% chg)

$0.55 (+1.43%)
Prev Close
$38.38
Open
$38.26
Day's High
$39.00
Day's Low
$38.14
Volume
2,531,048
Avg. Vol
2,326,954
52-wk High
$40.37
52-wk Low
$32.70

ABT.N

Chart for ABT.N

About

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals. Geographically, 30% of its revenue is generated in the United... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $60,071.73
Shares Outstanding (Mil.): 1,543.07
Dividend: 0.22
Yield (%): 2.26

Financials

  ABT.N Industry Sector
P/E (TTM): 25.63 33.26 33.35
EPS (TTM): 1.52 -- --
ROI: 5.46 19.66 18.92
ROE: 9.18 20.35 19.68
Search Stocks

Big Pharma still betting on "messed up" Indian drugs market

* Sector dogged by patent rows, price cuts, quality issues

12 Mar 2014

Danone could spend Medical Nutrition cash on baby food, dairy deals

PARIS, March 7 - If French food group Danone decides to sell its slowing medical nutrition business, it is most likely to invest the proceeds in its faster growth baby food and dairy businesses, targeting acquisitions in Asia and Africa.

07 Mar 2014

Gay juror's ouster forces new U.S. pharma trial

SAN FRANCISCO - A gay man was improperly excluded from jury service because of his sexual orientation, a federal appeals court has ruled, illustrating the widening influence of a key U.S. Supreme Court decision on gay rights.

21 Jan 2014

UPDATE 3-Gay juror's ouster forces new U.S. pharma trial

SAN FRANCISCO, Jan 21 - A gay man was improperly excluded from jury service because of his sexual orientation, a federal appeals court has ruled, illustrating the widening influence of a key U.S. Supreme Court decision on gay rights.

21 Jan 2014

GSK gets new trial against Abbott over gay juror issue -U.S. court

SAN FRANCISCO, Jan 21 - GlaxoSmithKline Plc deserves a new trial against Abbott Laboratories because Abbott impermissibly excluded a potential juror based on his sexual orientation, a federal appeals court ruled on Tuesday.

21 Jan 2014

Abbott Labs settles with U.S. over kickback claims

- Abbott Laboratories has agreed to pay the United States $5.48 million to resolve allegations that it paid improper kickbacks to induce doctors to use some of its products, the U.S. Department of Justice said on Friday.

27 Dec 2013

Abbott Labs settles with U.S. over kickback claims

Dec 27 - Abbott Laboratories has agreed to pay the United States $5.48 million to resolve allegations that it paid improper kickbacks to induce doctors to use some of its products, the U.S. Department of Justice said on Friday.

27 Dec 2013

Fonterra challenged in China's fast-growing milk powder market

SHANGHAI/WELLINGTON - Milk powder buyers in China are starting to cut their reliance on New Zealand's Fonterra , opening the way for U.S. and European firms to break the dairy giant's grip on an infant milk formula market set to double to $25 billion by 2017.

16 Dec 2013

FDA approves Abbott device for leaking heart valve

- The U.S. Food and Drug Administration has approved Abbott Laboratories' MitraClip medical device, used to stop heart valve leakage in patients deemed unable to endure valve repair through open heart surgery, the company said on Friday.

25 Oct 2013

UPDATE 1-U.S. FDA approves Abbott device for leaking heart valve

Oct 25 - The U.S. Food and Drug Administration has approved Abbott Laboratories' MitraClip medical device, used to stop heart valve leakage in patients deemed unable to endure valve repair through open heart surgery, the company said on Friday.

25 Oct 2013

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $98.96 +0.21
Pfizer Inc. (PFE.N) $30.25 +0.16
Novartis AG (NOVN.VX) CHF74.70 +0.35
Merck & Co., Inc. (MRK.N) $56.47 +0.21
Sanofi SA (SASY.PA) €75.48 +0.71
AstraZeneca plc (AZN.L) 3,781.50p +23.00
GlaxoSmithKline plc (GSK.L) 1,559.00p -4.50
Eli Lilly and Co (LLY.N) $60.43 +0.47
Amgen, Inc. (AMGN.OQ) $115.46 -0.08
Medtronic, Inc. (MDT.N) $58.55 +0.06

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$92.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks